These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9253545)

  • 61. Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: the Cardiovascular Risk in Young Finns Study.
    Lehtimäki T; Porkka K; Viikari J; Ehnholm C; Akerblom HK; Nikkari T
    Pediatrics; 1994 Oct; 94(4 Pt 1):489-93. PubMed ID: 7936857
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease.
    Dupuy AM; Mas E; Ritchie K; Descomps B; Badiou S; Cristol JP; Touchon J
    Gerontology; 2001; 47(4):213-8. PubMed ID: 11408727
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study.
    Grönroos P; Raitakari OT; Kähönen M; Hutri-Kähönen N; Marniemi J; Viikari J; Lehtimäki T
    Clin Chem Lab Med; 2007; 45(5):592-8. PubMed ID: 17484618
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differences in the binding capacity of human apolipoprotein E3 and E4 to size-fractionated lipid emulsions.
    Perugini MA; Schuck P; Howlett GJ
    Eur J Biochem; 2002 Dec; 269(23):5939-49. PubMed ID: 12444983
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lipid and carbohydrate studies in coronary artery disease.
    Falsetti HL; Schnatz JD; Greene DG; Bunnell IL
    Circulation; 1968 Feb; 37(2):184-91. PubMed ID: 5640347
    [No Abstract]   [Full Text] [Related]  

  • 66. Apolipoprotein epsilon 4 homozygosity--a determinant of restenosis after coronary angioplasty.
    van Bockxmeer FM; Mamotte CD; Gibbons FR; Taylor RR
    Atherosclerosis; 1994 Oct; 110(2):195-202. PubMed ID: 7848369
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regional differences in apolipoprotein E polymorphism in Finland.
    Lehtimäki T; Moilanen T; Nikkari T; Solakivi T; Porkka K; Ehnholm C; Rönnemaa T; Akerblom HK; Uhari M; Nuutinen EM
    Ann Med; 1991 Feb; 23(1):61-6. PubMed ID: 2036207
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.
    Mahley RW
    Science; 1988 Apr; 240(4852):622-30. PubMed ID: 3283935
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.
    Pedro-Botet J; Sentí M; Nogués X; Rubiés-Prat J; Roquer J; D'Olhaberriague L; Olivé J
    Stroke; 1992 Nov; 23(11):1556-62. PubMed ID: 1440702
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Apolipoprotein epsilon 4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty.
    Damaraju S; Yu QT; Safavi F; Marian AJ
    Am J Cardiol; 1995 Jun; 75(16):1181-3. PubMed ID: 7762511
    [No Abstract]   [Full Text] [Related]  

  • 71. Apolipoprotein E gene polymorphism and gender.
    Kolovou G; Damaskos D; Anagnostopoulou K; Cokkinos DV
    Ann Clin Lab Sci; 2009; 39(2):120-33. PubMed ID: 19429797
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Advances in molecular genetics and pathology of cerebrovascular disorders.
    Kalaria RN
    Trends Neurosci; 2001 Jul; 24(7):392-400. PubMed ID: 11410270
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study.
    Couderc R; Mahieux F; Bailleul S; Fenelon G; Mary R; Fermanian J
    Stroke; 1993 May; 24(5):661-4. PubMed ID: 8488520
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Connections between apolipoprotein E genotypes and the development of cardiovascular diseases].
    Végh C; Langmár Z; Szerző M; Agota A; Marosi K; Szabolcs Z; Nagy ZB
    Orv Hetil; 2012 Dec; 153(52):2070-6. PubMed ID: 23261995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apolipoprotein E polymorphism: automated determination of apolipoprotein E2, E3, and E4 isoforms.
    Wiebe C; Holzem G; Wielckens K; Klingler KR
    Lipids; 2000 Jan; 35(1):99-104. PubMed ID: 10695930
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
    Petrovic D; Zorc M; Peterlin B
    Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function.
    Kahraman S; Kiykim AA; Altun B; Gençtoy G; Arici M; Gulsun M; Erdem Y; Yasavul U; Turgan C; Cağlar S
    Clin Transplant; 2004 Jun; 18(3):288-94. PubMed ID: 15142050
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Association of apolipoprotein E gene polymorphism with early-onset coronary heart disease and its effect on plasma lipid levels].
    Peng S; Peng J; Gong W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):375-8. PubMed ID: 11592046
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease.
    MCarron MO; Muir KW; Weir CJ; Dyker AG; Bone I; Nicoll JA; Lees KR
    Stroke; 1998 Sep; 29(9):1882-7. PubMed ID: 9731613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.